These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 28328595)

  • 1. Hemorrhage and Infarction of the Conjunctiva and Orbit in Essential Thrombocythemia.
    Na J; Choi SY; Baek S; Lee H
    J Craniofac Surg; 2017 May; 28(3):750-751. PubMed ID: 28328595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment outcome of patients with essential thrombocythemia at our department in Hungary].
    Iványi JL; Marton É; Plander M; Szendrei T
    Orv Hetil; 2016 Feb; 157(9):336-41. PubMed ID: 26895801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia.
    Harrison CN; Campbell PJ; Buck G; Wheatley K; East CL; Bareford D; Wilkins BS; van der Walt JD; Reilly JT; Grigg AP; Revell P; Woodcock BE; Green AR;
    N Engl J Med; 2005 Jul; 353(1):33-45. PubMed ID: 16000354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anagrelide influences thrombotic risk, and prolongs progression-free and overall survival in essential thrombocythaemia vs hydroxyurea plus aspirin.
    Kellner A; Dombi P; Illes A; Demeter J; Homor L; Ercsei I; Simon Z; Karadi E; Herczeg J; Gy Korom V; Gasztonyi Z; Szerafin L; Udvardy M; Egyed M
    Eur J Haematol; 2020 Oct; 105(4):408-418. PubMed ID: 32557810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anagrelide compared with hydroxyurea in essential thrombocythemia: a meta-analysis.
    Samuelson B; Chai-Adisaksopha C; Garcia D
    J Thromb Thrombolysis; 2015 Nov; 40(4):474-9. PubMed ID: 25894476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful management of acute bleeding in essential thrombocythemia using automated cell separator.
    Singh A; Chaudhary R; Nityanand S
    Transfus Apher Sci; 2014 Feb; 50(1):56-8. PubMed ID: 24325890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary localized conjunctival amyloidosis presenting with recurrence of subconjunctival hemorrhage.
    Lee HM; Naor J; DeAngelis D; Rootman DS
    Am J Ophthalmol; 2000 Feb; 129(2):245-7. PubMed ID: 10682979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Essential thrombocythemia accompanied by adrenal infarction].
    Iemura T; Mano C; Oba A; Kawabata N; Horisawa Y; Matsui M; Miyahara Y; Itoh M
    Rinsho Ketsueki; 2019; 60(2):106-111. PubMed ID: 30842376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anagrelide reduces thrombotic risk in essential thrombocythaemia vs. hydroxyurea plus aspirin.
    Dombi P; Illés Á; Demeter J; Homor L; Simon Z; Karadi E; Udvardy M; Egyed M
    Eur J Haematol; 2017 Feb; 98(2):106-111. PubMed ID: 27557754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anagrelide: a review of its use in the management of essential thrombocythaemia.
    Wagstaff AJ; Keating GM
    Drugs; 2006; 66(1):111-31. PubMed ID: 16398570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxyurea and anagrelide combination therapy in patients with chronic myeloproliferative diseases resistant or intolerant to monotherapy.
    Christoforidou A; Pantelidou D; Anastasiadis A; Goutzouvelidis A; Margaritis D; Kotsianidis I; Spanoudakis E; Kaloutsi V; Bourikas G; Tsatalas C
    Acta Haematol; 2008; 120(4):195-8. PubMed ID: 19129692
    [No Abstract]   [Full Text] [Related]  

  • 12. Cerebral infarct in a patient with a history of systemic arterial and venous thrombosis from essential thrombocythemia.
    Kim KT; Sohn SI; Cho KH
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):913.e9-10. PubMed ID: 22305797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presumed orbital sarcoidosis: report of a case followed by computerized axial tomography and conjunctival biopsy.
    Nichols CW; Mishkin M; Yanoff M
    Trans Am Ophthalmol Soc; 1978; 76():67-75. PubMed ID: 754385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of essential thrombocythemia].
    Alvarez-Larrán A; Cervantes F; Besses C
    Med Clin (Barc); 2013 Sep; 141(6):260-4. PubMed ID: 23490491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. When and how to treat essential thrombocythemia.
    Barbui T; Finazzi G
    N Engl J Med; 2005 Jul; 353(1):85-6. PubMed ID: 16000360
    [No Abstract]   [Full Text] [Related]  

  • 16. Orbital subperiosteal hemorrhage while scuba diving.
    Gómez-Ledesma I; Mencía-Gutíerrez E; Gutiérrez-Díaz E; Alonso-Santiago MA
    Orbit; 2006 Mar; 25(1):19-22. PubMed ID: 16527770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Essential thrombocythemia-related acute ST-segment elevation myocardial infarction. A case report and literature review.
    Daya SK; Gowda RM; Landis WA; Khan IA
    Angiology; 2004; 55(3):319-23. PubMed ID: 15156266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of the risk of thrombosis or bleeding upon abrupt anagrelide discontinuation in patients with essential thrombocythemia.
    Santaliestra M; Ferrer-Marín F; Alvarez-Larrán A;
    Ann Hematol; 2022 Nov; 101(11):2563-2564. PubMed ID: 35978180
    [No Abstract]   [Full Text] [Related]  

  • 19. Subconjunctival hemorrhage and conjunctivochalasis.
    Mimura T; Usui T; Yamagami S; Funatsu H; Noma H; Honda N; Fukuoka S; Shirakawa R; Hotta H; Amano S
    Ophthalmology; 2009 Oct; 116(10):1880-6. PubMed ID: 19596440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute coronary syndrome associated with essential thrombocythemia.
    Kumagai N; Mitsutake R; Miura S; Kawamura A; Takamiya Y; Nishikawa H; Uehara Y; Saku K
    J Cardiol; 2009 Dec; 54(3):485-9. PubMed ID: 19944327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.